Normal and abnormal calcium homeostasis in neurons: A basis for the pathophysiology of traumatic and ischemic central nervous system injury

Neurosurgery

Volumn 38, Issue 6, 1996, Pages 1176-1195

  Tymianski, Michael ^a   Tator, Charles H ^b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b NONE

Author keywords

Anoxia; Calcium; Calcium homeostasis; Cerebral ischemia; Neurotoxicity

Indexed keywords

2,4 DIAMINO 5 (2,3,5 TRICHLOROPHENYL)PYRIMIDINE; 4 (3 PHOSPHONOALLYL) 2 PIPERAZINECARBOXYLIC ACID; 4 PHOSPHONOMETHYLPIPECOLIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ADENOSINE TRIPHOSPHATASE (CALCIUM); BUFFER; CALCINEURIN; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHELATING AGENT; CALCIUM ION; CYTOPLASM PROTEIN; DANTROLENE; DIZOCILPINE; ENDONUCLEASE; EXCITATORY AMINO ACID; FREE RADICAL; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; ION CHANNEL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; NIMODIPINE; NITRIC OXIDE SYNTHASE; OPIATE ANTAGONIST; PHENYTOIN; PROTEIN KINASE; PROTEINASE INHIBITOR; SCAVENGER; SUPEROXIDE DISMUTASE MACROGOL; TROMETAMOL; UNINDEXED DRUG;

ACIDOSIS; APOPTOSIS; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; DIAGNOSIS; HUMAN; MITOCHONDRION; NERVE CELL; NERVE DEGENERATION; NERVOUS SYSTEM INJURY; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW;

ANIMALS; BRAIN DAMAGE, CHRONIC; BRAIN INJURIES; BRAIN ISCHEMIA; CALCIUM; CALCIUM CHANNELS; HOMEOSTASIS; HUMANS; NERVE DEGENERATION; NEURONS;

EID: 0030015166     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199606000-00028     Document Type: Review

References (300)

1. Abele AE, Scholz KP, Scholz WK, Miller RJ: Excitotoxicity induced by enhanced excitatory neurotransmission in cultured hippocampal pyramidal neurons Neuron 4:413-419, 1990.
2. Adler EM, Augustine GJ, Duffy SN, Charlton MP: Alien intracellular calcium chelators attenuate neurotransmitter release at the squid giant synapse. J Neurosci 11:1496-1507, 1991.
3. Aizenman E, Hartnett KA, Reynolds IJ: Oxygen free radicals regulate NMDA receptor function via a redox modulatory site. Neuron 5:841-846, 1990.
4. Astrup J, Siesjo BK, Symon L: Thresholds in cerebral ischemia: The ischemic penumbra. Stroke 12:723-725, 1981.
5. Augustine GJ, Adler EM, Charlton MP: The calcium signal for transmitter secretion from presynaptic nerve terminals. Ann N Y Acad Sci 635:365-381, 1991.
6. Augustine GJ, Charlton MP, Smith SJ: Calcium entry into voltage-lamped presynaptic terminals of squid. J Physiol 367: 143-162, 1985.
7. Bading H, Ginty DD, Greenberg ME: Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science 260:181-186, 1993.
8. Baimbridge KG, Celio MR, Rogers JH: Calcium-binding proteins in the nervous system. Trends Neurosci 15:303-308, 1992.
9. Baker AJ, Moulton RJ, MacMillan VH, Shedden PM: Excitatory amino acids in cerebrospinal fluid following traumatic brain injury in humans. J Neurosurg 79:369-372, 1993.
10. Balentine JD: Spinal cord trauma: In search of the meaning of granular axoplasm and vesicular myelin. J Neuropathol Exp Neurol 47:77-92, 1988.
11. Balentine JD, Paris DU, Dean DL: Calcium-induced spongiform and necrotizing myelopathy. Lab Invest 47:286-295, 1982.
12. Balentine JD, Paris DU, Greene WB: Ultrastructural pathology of nerve fibers in calcium-induced myelopathy. J Neuropathol Exp Neurol 43:500-510, 1984.
13. Barinaga M: Is nitric oxide the "retrograde messenger?" Science 254:1296-1297, 1991.
14. Beckman JS: The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J Dev Physiol 15:53-59, 1991.
15. Benveniste H, Drejer J, Schousboe A, Diemer NH: Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 43:1369-1374, 1984.
16. Blaustein MP: Calcium transport and buffering in neurons. Trends Neuro Sci 11:438-443, 1988.
17. Boast CA, Gerhardt SC, Pastor G, Lehmann J, Etienne PE, Liebman JM: The N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils. Brain Res 442: 345-348, 1988.
18. Boitano S, Dirksen ER, Sanderson MJ: Intercellular propagation of calcium waves mediated by inositol triphosphate. Science 258:292-295, 1992.
19. Boxer PA, Cordon JJ, Mann ME, Rodolosi LC, Vartanian MG, Rock DM, Taylor CP, Marcoux FW: Comparison of phenytoin with non-competitive N-methyl-D-aspartate antagonists in a model of focal brain ischemia. Stroke 21[Suppl 11]:III47-III51, 1990.
20. Bracken MB, Holford TR: Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2. J Neurosurg 79:500-507, 1993.
21. Bracken MB, Shepard MJ, Collins WF Jr, Holford TR, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon JC, Marshall LF, Perot PL Jr, Piepmeier J, Sonntag VKH, Wagner FC Jr, Wilberger JL, Winn HR, Young W: Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data - Results of the second National Acute Spinal Cord Injury Study. J Neurosurg 76:23-31, 1992.
22. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon J, Marshall LF, Perot PL Jr, Piepmeier J, Sonntag VKH, Wagner FC, Wilberger JE, Winn HR: A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury: Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 322:1405-1411, 1990.
23. Bredt DS, Snyder SH: Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A 87:682-685, 1990.
24. Bredt DS, Hwang PM, Snyder SH: Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347: 768-770, 1990.
25. Brose N, Petrenko AG, Sudhof TC, Jahn R: Synaptotagmin: A calcium sensor on the synaptic vesicle surface. Science 256:1021-1025, 1992.
26. 2+-channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia. J Cereb Blood Flow Metab 14:903-910, 1994.
27. Buchan AM, Li H, Sunghee C, Pulsinelli WA: Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats. Neurosci Lett 132:255-258, 1991.
28. Buchan AM, Xue D, Huang ZG, Smith KE, Lesiuk H: Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia. Neuroreport 2:473-476, 1991.
29. Buisson A, Plotkine M, Boulu RG: The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischaemia. Br J Pharmacol 106:766-767, 1992.
30. Bullock R, McCulloch J, Graham DI, Lowe D, Chen MH, Teasdale GM: Focal ischemic damage is reduced by CPP-ene studies in two animal models. Stroke [Suppl]21:11132-11136, 1990.
31. 2+ pump of the plasma membrane. J Biol Chem 267:2115-2118, 1992.
32. Chan PH, Yang GY, Chen SF, Carlson E, Epstein CJ: Cold-induced brain edema and infarction are reduced in transgenic mice overexpressing CuZn-superoxide-dismutase. Ann Neurol 29:482-486, 1991.
33. Chard PS, Bleakman D, Christakos S, Fullmer CS, Miller RJ: Calcium buffering properties of calbindin D28k and parvalbumin in rat sensory neurones. J Physiol 472:341-357, 1993.
34. Chen ST, Hsu CY, Hogan EL, Juan HY, Banik NL, Balentine JD: Brain calcium content in ischemic infarction. Neurology 37:1227-1229, 1987.
35. Cheng B, Mattson MP: NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron 7:1031-1041, 1991.
36. Cheung JY, Bonventre JV, Malis CD, Leaf A: Calcium and ischemic injury. N Engl J Med 314:1670-1676, 1986.
37. Choi DW: Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett 58:293-297, 1985.
38. Choi DW: Ionic dependence of glutamate neurotoxicity. J Neurosci 7:369-379, 1987.
39. Choi DW: Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage. Trends Neurosci 11:465-467, 1988.
40. Choi DW: Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634, 1988.
41. Choi DW: Cerebral hypoxia: Some new approaches and unanswered questions. J Neurosci 10:2493-2501, 1990.
42. Choi DW, Koh JY, Peters S: Pharmacology of glutamate neurotoxicity in cortical cell culture: Attenuation by NMDA antagonists. J Neurosci 8:185-196, 1988.
43. Choi DW, Maulucci-Gedde M, Kriegstein AR: Glutamate neurotoxicity in cortical cell culture. J Neurosci 7:357-368, 1987.
44. 2+ channels on frog motor nerve terminals revealed by fluorescent ω-conotoxin. J Neurosci 11:1032-1039, 1991.
45. Collinridge GL, Singer W: Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol Sci 11:290-296, 1990.
46. Cox JA, Lysko PG, Henneberry RC: Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: Role of the voltage-dependent magnesium block. Brain Res 499:267-272, 1989.
47. Coyle JT, Puttfarcken P: Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-695, 1993.
48. 1H nuclear magnetic resonance spectroscopy: II - Changes during ischaemia. J Cereb Blood Flow Metab 7:394-402, 1987.
49. Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH: Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci U S A 88:7797-7801, 1991.
50. Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH: Mechanism of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 13:2651-2661, 1993.
51. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH: Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A 88:6368-6371, 1991.
52. 2+ dynamics after toxic doses of glutamate in cerebellar granule cells. Proc Natl Acad Sci U S A 87:8017-8021, 1990.
53. Deshpande JK, Siesjo BK, Wieloch T: Calcium accumulation and neuronal damage in the rat hippocampus following cerebral ischemia. J Cereb Blood Flow Metab 7:89-95, 1987.
54. Dessi F, Charriaut-Marlangue C, Khrestchatisky M, Ben-Ari Y: Glutamate-induced neuronal death is not a programmed cell death in cerebellar cultures. J Neurochem 60:1953-1955, 1993.
55. Dingledine R, Boland LM, Chamberlin NL, Kawasaki K, Kleckner NW, Traynelis SF, Verdoorn TA: Amino acid receptors and uptake systems in the mammalian central nervous system. CRC Crit Rev Neurobiol 4:1-97, 1988.
56. Dubinsky JM, Rothman SM: Intracellular calcium concentration during "chemical hypoxia" and excitotoxic neuronal injury. J Neurosci 11:2545-2551, 1991.
57. Dumuis A, Sebben M, Haynes L, Pin JP, Bockaert J: NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature 336:68-70, 1988.
58. During MJ, Spencer DD: Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 341:1607-1610, 1993.
59. East SJ, Garthwaite J: NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the L-arginine-nitric oxide pathway. Neurosci Lett 123:17-19, 1991.
60. Eimrel S, Schramm M: The quantity of calcium that appears to induce neuronal death. J Neurochem 62:1223-1226, 1994.
61. Ellren K, Lehmann A: Calcium dependency of N-methyl-D-aspartate toxicity in slices from the immature rat hippocampus. Neuroscience 32:371-379, 1989.
62. Faden AI, Salzman S: Pharmacological strategies in CNS trauma. Trends Pharmacol Sci 13:29-35, 1992.
63. Deleted in proof.
64. Faden AI, Demediuk P, Panter SS, Vink P: The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244:798-800, 1989.
65. Fariss MW, Pascoe GA, Reed DJ: Vitamin E reversal of the effect of extracellular calcium on induced toxicity in hepatocytes. Science 227:751-754, 1985.
66. Farooqui AA, Horrocks LA: Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders. Brain Res Brain Res Rev 16:171-191, 1991.
67. Favaron M, Manev H, Siman R, Bertolino M, Szekely AM, DeErausquin G, Guidotti A, Costa E: Down-regulation of protein kinase C protects cerebellar granule neurons in primary culture from glutamate-induced neuronal death. Proc Natl Acad Sci U S A 87:1983-1987, 1990.
68. Fehlings MG, Tator CH, Linden RD: The effect of nimodipine and dextran on axonal function and blood flow following experimental spinal cord injury. J Neurosurg 71:403-416, 1989.
69. Ford RWJ, Malm DN: Failure of nimodipine to reverse acute experimental spinal cord injury. Cent Nerv Syst Trauma 2:9-16, 1985.
70. 2+ release from intracellular stores in cultured cerebral cortical neurons. J Neurochem 56:1075-1078, 1991.
71. Freund TF, Buzsaki G, Leon A, Baimbridge KG, Somogyi P: Relationship of neuronal vulnerability and calcium binding protein immunoreactivity in ischemia. Exp Brain Res 83:55-66, 1990.
72. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376, 1980.
73. Gaab MR, Seegers K, Smedema RJ, Heissler HE, Goetz C: A comparative analysis of THAM (Tris-buffer) in traumatic brain oedema. Acta Neurochir Suppl (Wien) 51:320-323, 1990.
74. 1H nuclear magnetic resonance spectroscopy - I: Methodology. J Cereb Blood Flow Metab 7:199-206, 1987.
75. Garthwaite J, Garthwaite G: The mechanism of kainic acid neurotoxicity. Nature 305:138-140, 1983.
76. Garthwaite G, Garthwaite J: Neurotoxicity of excitatory amino acid receptor agonists in rat cerebellar slices: Dependence on calcium concentration. Neurosci Lett 66:193-198, 1986.
77. Geisler FH, Dorsey FC, Coleman WP: Recovery of motor function after spinal-cord injury: A randomized, placebo-controlled trial with GM-1 ganglioside. N Engl J Med 324:1829-1838, 1991 (published erratum appears in N Engl J Med 325:1659-1660, 1991).
78. Geisler FH, Dorsey FC, Coleman WP: GM-1 ganglioside in human spinal cord injury. J Neurotrauma 9[Suppl 2]:S517-S530, 1992.
79. Gelmers HJ, Hennerici M: Effect of nimodipine on acute ischemic stroke: Pooled results from five randomized trials. Stroke [Suppl]21:IV81-IV84, 1990.
80. Gibbons SJ, Brorson JR, Bleakman D, Chard PS, Miller RJ: Calcium influx and neurodegeneration. Ann N Y Acad Sci 679:22-33, 1993.
81. Giffard RG, Monyer H, Christine CW, Choi DW: Acidosis reduces NMDA receptor activation, glutamate neurotoxicity, and oxygen-glucose deprivation neuronal injury in cortical cultures. Brain Res 506:339-342, 1990.
82. Gilbertson TA, Scobey R, Wilson M: Permeation of calcium ions through non-NMDA glutamate channels in retinal bipolar cells. Science 251:1613-1615, 1991.
83. Globus MY-T, Wester P, Busto R, Dietrich WD: Ischemia-induced extracellular release of serotonin plays a role in CA1 neuronal cell death in rats. Stroke 23:1595-1601, 1992.
84. Goldberg MP, Giffard RG, Kurth MC, Choi DW: Role of extracellular calcium and magnesium in ischemic neuronal injury in vitro. Neurology 39[Suppl]:217, 1989 (abstr).
85. Goldberg MP, Weiss JH, Pham PC, Choi DW: N-methyl-D-aspartate receptors mediate hypoxic neuronal injury in cortical culture. J Pharmacol Exp Ther 243:784-791, 1987.
86. Graham SH, Chen J, Sharp FR, Simon RP: Limiting ischemic injury by inhibition of excitatory amino acid release. J Cereb Blood Flow Metab 13:88-97, 1993.
87. Grotta JC, Pettigrew LC, Rosenbaum D, Reid C, Rhodes H, McCandless D: Efficacy and mechanism of action of a calcium channel blocker after global cerebral ischemia in rats. Stroke 19:447-454, 1988.
88. Guha A, Tator CH, Smith CR, Piper I: Improvement in post-traumatic spinal cord blood flow with a combination of a calcium channel blocker and a vasopressor. J Trauma 29:1440-1447, 1989.
89. Gunter TE, Pfeiffer DR: Mechanisms by which mitochondria transport calcium. Am J Physiol 258:C755-C786, 1990.
90. Halestrap AP, Griffiths EJ, Connern CP: Mitochondrial calcium handling and oxidative stress. Biochem Soc Trans 21:353-358, 1993.
91. Hall ED: The neuroprotective pharmacology of methylprednisolone. J Neurosurg 76:13-22, 1992.
92. Hall ED: Neuroprotective actions of glucocorticoid and nonglucocorticoid steroids in acute neuronal injury. Cell Mol Neurobiol 13:415-432, 1993.
93. Hansen AJ, Zeuthen T: Extracellular ion concentrations during spreading depression and ischemia in the rat brain cortex. Acta Physiol Scand 113:437-445, 1981.
94. Hartley Z, Dubinsky JM: Changes in intracellular pH associated with glutamate excitotoxicity. J Neurosci 13:4690-4699, 1993.
95. 2+ accumulation in cortical cell culture correlates with subsequent neuronal degeneration. J Neurosci 13:1993-2000, 1993.
96. Herman B, Gores GJ, Nieminen AL, Kawanishi T, Harman A, Lemasters JJ: Calcium and pH in anoxic and toxic injury. Crit Rev Toxicol 21:127-148, 1990.
97. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252:851-853, 1991.
98. Honore T, Davies SN, Drejer J, Fletcher EJ, Jacobsen P, Lodge D, Nielsen FE: Quinoxalinediones: Potent competitive non-NMDA glutamate receptor antagonists. Science 241:701-703, 1988.
99. Hope BT, Michael GJ, Knigge KM, Vincent SR: Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci U S A 88:2811-2814, 1991.
100. 2+ dependence. Brain Res 358:380-384, 1985.
101. Iadecola C, Pelligrino DA, Moscowitz MA, Lassen NA: State of the art review: Nitric oxide inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab 14:175-192, 1994.
102. Iino M, Ozawa S, Tsuzuki K: Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurons. J Physiol 424:151-165, 1990.
103. Irwin RP, Paul SM: Glutamate exposure rapidly decreases intracellular pH in rat hippocampal neurons in culture. Soc Neurosci Abstr 18:118.10, 1992.
104. Jahromi BS, Robitaille R, Charlton MP: Transmitter release increases intracellular calcium in perisynaptic Schwann cells in situ. Neuron 8:1069-1077, 1992.
105. Jancso G, Karcsu S, Kiraly E, Szebeni A, Toth L, Bacsy E, Joo F, Parducz A: Neurotoxin induced nerve cell degeneration: Possible involvement of calcium. Brain Res 295:211-216, 1984.
106. 2+ channels in hippocampal CA1 neurons. Science 244:1189-1193, 1989.
107. Kajita Y, Suzuki Y, Uyama H, Tanazawa T, Takayasu M, Shibuya M, Sugita K: Combined effect of L-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs. J Neurosurg 80:476-483, 1994.
108. Kaku DA, Giffard RG, Choi DW: Neuroprotective effects of glutamate antagonists and extracellular acidity. Science 260: 1516-1518, 1993.
109. Kaku DA, Goldberg MP, Choi DW: Antagonism of non-NMDA receptors augments the neuroprotective effect of NMDA receptor blockade in cortical cultures subjected to prolonged deprivation of oxygen and glucose. Brain Res 554:344-347, 1991.
110. Kamiya H, Sawada S, Yamamoto CY: Synthetic ω-conotoxin blocks synaptic transmission in the hippocampus in vitro. Neurosci Lett 91:84-88, 1988.
111. Kasai H, Peterson OH: Spatial dynamics of second messengers: IP3 and cAMP as long-range and associative messengers. Trends Neurosci 17:95-101, 1994.
112. Kass IS, Lipton P: Mechanisms involved in irreversible anoxic damage to the in vitro rat hippocampal slice. J Physiol 332:459-472, 1982.
113. Kass IS, Cottrell JE, Chambers G: Magnesium and cobalt, not nimodipine, protect neurons against anoxic damage in the rat hippocampal slice. Anaesthesiology 69:710-715, 1988.
114. Kater SB, Mattson MP, Guthrie PB: Calcium-induced neuronal degeneration: A normal growth cone regulating signal gone awry. Ann N Y Acad Sci 568:252-261, 1989.
115. Kiedrowski L, Brooker G, Costa E, Wroblewski JT: Glutamate impairs neuronal calcium extrusion while reducing sodium gradient. Neuron 12:295-300, 1994.
116. Kirino T: Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 239:57-69, 1982.
117. Kirino T, Robinson HPC, Miwa A, Tamura A, Kawai N: Disturbance of membrane function preceding ischemic delayed neuronal death in the gerbil hippocampus. J Cereb Blood Flow Metab 12:408-417, 1992.
118. Kitamura Y, Miyazaki A, Yamanaka Y, Nomura Y: Stimulatory effects of protein kinase C and calmodulin kinase II on N-methyl-D-aspartate receptor/channels in the postsynaptic density of rat brain. J Neurochem 61:100-109, 1993.
119. Koch RA, Barish ME: Perturbation of intracellular calcium and hydrogen ion regulation in cultured mouse hippocampal neurons by reduction of the sodium ion concentration gradient. J Neurosci 14:2585-2593, 1994.
120. Kochhar A, Zivin JA, Lyden PD, Mazzarella V: Glutamate antagonist therapy reduces neurologic deficit produced by focal central nervous sytem ischemia. Arch Neurol 45:148-153, 1988.
121. Koh JY, Goldberg MP, Hartley DM, Choi DW: Non-NMDA receptor-mediated neurotoxicity in cortical culture. J Neurosci 10:696-705, 1990.
122. Koyanagi I, Tator CH, Lea PJ: Three-dimensional analysis of the vascular system in the rat spinal cord with scanning electron microscopy of vascular corrosion casts: Part 2 - Acute spinal cord injury. Neurosurgery 33:284-292, 1993.
123. Krnjevic K, Xu YZ: Dantrolene suppresses the hyerpolarization or outward current observed during anoxia in hippocampal neurons. Can J Physiol Pharmacol 67:1602-1604, 1989.
124. 2+ overload. Brain Res 528:48-54, 1990.
125. Kure S, Tominaga T, Yoshimoto T, Tada K, Narisawa K: Glutamate triggers internucleosomal DNA cleavage in neuronal cells. Biochem Biophys Res Comm 179:39-45, 1991.
126. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J: NMDA-dependent superoxide production and neurotoxicity. Nature 364:535-537, 1993.
127. LaManna JC, McCracken KA: The use of neutral red as an intracellular pH indicator in rat brain cortex in vivo. Anal Biochem 142:117-125, 1984.
128. Lechleiter JD, Clapham DE: Molecular mechanisms of intracellular calcium excitability in X. laevis oocytes. Cell 69:283-294, 1992.
129. Lei SZ, Pan ZH, Aggarwal SK, Chen HSV, Hartman J, Sucher NJ, Lipton SA: Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 8:1087-1099, 1992.
130. Lemasters JJ, DiGiuseppi JD, Nieminen AL, Herman B: Blebbing, free calcium and mitochondrial membrane potential preceding cell death in hepatocytes. Nature 325:78-81, 1987.
131. Lerea LS, McNamara JO: Ionotropic glutamate receptor subtypes activate c-fos transcription by distinct calcium-requiring intracellular signaling pathways. Neuron 10:31-41, 1993.
132. Lipton SA, Rosenberg PA: Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330: 613-622, 1994.
133. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen SHV, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS: A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626-631, 1993.
134. Liu D, Thangnipon W, McAdoo DJ: Excitatory amino acids rise to toxic levels upon impact injury to the rat spinal cord. Brain Res 547:344-348, 1991.
135. Llano L, DiPolo R, Marty A: Calcium-induced calcium release in cerebellar purkinje cells. Neuron 12:663-673, 1994.
136. Lledo PM, Somasundram B, Morton AJ, Emson PC, Mason WT: Stable transfection of calbindin-D28k into the GH3 cell line alters calcium currents and intracellular calcium homeostasis. Neuron 9:943-954, 1992.
137. Llinas R, Sugimori M, Silver RB: Microdomains of high calcium concentration in a presynaptic terminal. Science 256:677-679, 1992.
138. Lobner D, Lipton P: Intracellular calcium levels and calcium fluxes in the CA1 region of the rat hippocampal slice during in vitro ischemia: Relationship to electrophysiological cell damage. J Neurosci 13:4861-4871, 1993.
139. Lucas DR, Newhouse JP: The toxic effect of sodium L-glutamate on the inner layers of the retina. Arch Ophthalmol 58:193-201, 1957.
140. Lucas JH, Gross GW, Emery DG, Gardner CR: Neuronal survival or death after dendrite transaction close to the perikaryon: Correlation with electrophysiologic, morphologic, and ultrastructural changes. Cent Nerv Syst Trauma 2:231-255, 1985.
141. 2+]i level and pump-leak turnover in intact red cells measured using an incorporated Ca chelator. Nature 298:478-481, 1982.
142. MacDermott AB, Mayer ML, Westbrook GL, Smith SJ, Barker JL: NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons. Nature 321:519-522, 1986.
143. Madden KP, Clark WM, Marcoux FW, Probert AW Jr, Weber ML, Rivier J, Zivin JA: Treatment with conotoxin, an "N-type" calcium channel blocker, in neuronal hypoxic-ischemic injury. Brain Res 537:256-262, 1990.
144. Madison D: Pass the nitric oxide. Proc Natl Acad Sci U S A 90:4329-4331, 1993.
145. 2+ influx elicited by glutamate: Role in neuronal death. Mol Pharmacol 36:106-112, 1989.
146. Marcoux FW, Probert AW, Weber ML: Hypoxic neural injury in cell culture: Calcium accumulation blockade and neuroprotection by NMDA antagonists but not calcium channel antagonists, in Ginsberg MD, Dietrich WD (eds): Cerebrovascular Disease: Sixteenth Princeton Conference. New York, Raven Press, 1989, pp 135-141.
147. Marmarou A, Holdaway R, Ward JD, Yoshida K, Choi SC, Muizelaar JP, Young HF: Traumatic brain tissue acidosis: Experimental and clinical studies. Acta Neurochir Suppl (Wien) 57: 160-164, 1993.
148. Marty A, Neher E: Potassium Channels in cultured bovine adrenal chromaffin cells. J Physiol 367:117-141, 1985.
149. Matsumoto Y, Kamata T, Goto N: The suppression by nizofenone of the release of glutamate and lactate as a mechanism of its neuroprotective effect: An in vivo brain microdialysis study. J Cereb Blood Flow Metab 13[Suppl 1]:S742, 1993 (abstr).
150. Matsumoto K, Ueda S, Hashimoto T, Kuriyama K: Ischemic neuronal injury in the rat hippocampus following transient forebrain ischemia: Evaluation using in vivo microdialysis. Brain Res 543:236-242, 1991.
151. 2+ extrusion in protection against neuronal excitotoxicity. FASEB J 3:2519-2526, 1989.
152. Mattson MP, Kumar KN, Wang H, Cheng B, Michaelis EK: Basic FGF regulates the expression of a functional 71-kDa NMDA receptor protein that mediates calcium influx and neurotoxicity in hippocampal neurons. J Neurosci 13:4575-4588, 1993.
153. Mattson MP, Rychlik B, Chu C, Christakos S: Evidence for calcium-reducing and excito-protective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons. Neuron 6:41-51, 1991.
154. Mattson MP, Zhang Y, Bose S: Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis, and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose. Exp Neurol 121:1-13, 1993.
155. McCaslin PP, Smith TG: Quisqualate, high calcium concentration and zero-chloride prevent kainate-induced toxicity of cerebellar granule cells. Eur J Pharmacol 152:341-346, 1988.
156. McCleskey EW, Fox AP, Feldman DH, Cruz LJ, Olivera BM, Tsien RW, Yoshikami D: ω-Conotoxin: Direct and persistent blockade of specific types of calcium channels in neurons but not in muscle. Proc Natl Acad Sci U S A 84:4327-4331, 1987.
157. McIntosh TK: Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: A review. J Neurotrauma 10:215-261, 1993.
158. McLean AEM, McLean E, Judah JD: Cellular necrosis in the liver induced and modified by drugs. Int Rev Exp Pathol 4:127-157, 1965.
159. McPherson PS, Kim YK, Valdivia H, Knudson CM, Takekura H, Franzini-Armstrong C, Coronado R, Campbell KP: The brain ryanodine receptor: A caffeine-sensitive calcium release channel. Neuron 7:17-25, 1991.
160. Meldrum B: Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc Brain Metab Rev 2:27-57, 1990.
161. Michaels RL, Rothman SM: Glutamate neurotoxicity in vitro: Antagonist pharmacology and intracellular calcium concentrations. J Neurosci 10:283-292, 1990.
162. 2+ stores in neuronal and neuroendocrine cells. Cell Calcium 11: 191-199, 1990.
163. 2+: Getting it up and keeping it up. Trends Neuro Sci 15:317-319, 1992.
164. Muizelaar JP: Cerebral ischemia-reperfusion injury after severe head injury and its possible treatment with polyethyleneglycol-superoxide dismutase. Ann Emerg Med 22:1014-1021, 1993 (review).
165. Muizelaar JP, Marmarou A, Young HF, Choi SC, Wolf A, Schneider RL, Kontos HA: Improving the outcome of severe head injury with the oxygen radical scavenger polyethylene glycolconjugated superoxide dismutase: A Phase II trial. J Neurosurg 78:375-382, 1993.
166. Murphy SN, Miller RJ: A glutamate receptor regulates calcium mobilization in hippocampal neurons. Proc Natl Acad Sci U S A 85:8737-8741, 1988.
167. Murphy SM, Thayer SA, Miller RJ: The effects of excitatory amino acids on intracellular calcium in single mouse striatal neurons in vitro. J Neurosci 7:4145-4158, 1987.
168. Nachshen DA, Sanchez-Armass S, Weinstein AM: The regulation of cytosolic calcium in rat brain synaptosomes by sodium-dependent calcium efflux. J Physiol 381:17-28, 1986.
169. Nakanishi S: Molecular diversity of glutamate receptors and implications for brain function. Science 258:597-603, 1992.
170. Neering IR, McBurney RN: Role for microsomal Ca storage in mammalian neurones? Nature 309:158-160, 1984.
171. Neher E: Concentration profiles of intracellular calcium in the presence of a diffusible chelator, in Heinemann U, Klee M, Neher E (eds): Calcium Electrogenesis and Neuronal Functioning. Berlin-Heidelberg, Springer-Verlag, Exp Brain Res, Series 14, 1986, pp 80-96.
172. Neher E, Augustine GJ: Calcium gradients and buffers on bovine chromaffin cells. J Physiol 450:273-301, 1992.
173. Nicholson C, Bruggencate GT, Steinberg R, Stockle H: Calcium modulation in brain extracellular microenvironment demonstrated with ion selective micropipette. Proc Natl Acad Sci U S A 74:1287-1290, 1977.
174. Nicoll RA: The coupling of neurotransmitter receptors to ion channels in the brain. Science 241:545-551, 1988.
175. Niesen C, Charlton MP, Carlen PL: Postsynaptic and presynaptic effects of the calcium chelator BAPTA on synaptic transmission in rat hippocampal dentate granule neurons. Brain Res 555:319-325, 1991.
176. Nishikawa T, Kirsch JR, Koehler RC, Bredt DS, Snyder SH, Traystman RJ: Effects of nitric oxide synthase inhibition on cerebral blood flow and injury volume during focal cerebral ischemia in cats. Stroke 23:1717-1724, 1993.
177. Novelli A, Reilly JA, Lysko PG, Henneberry RC: Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 451:205-212, 1988.
178. Nowak L, Bregestovski P, Ascher P: Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307:462-465, 1984.
179. Nowycky MC, Pinter MJ: Time courses of calcium and calcium-bound buffers following calcium influx in a model cell. Biophys J 64:77-91, 1993.
180. O'Dell TJ, Hawkins RD, Kandel E, Arancio O: Tests of the roles of two diffusible substances in long-term potentiation: Evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci U S A 88:11285-11289, 1991.
181. Ojcius DM, Zychlinsky A, Zheng LM, Young D: Ionophore-induced apoptosis: Role of DNA fragmentation and calcium fluxes. Exp Cell Res 197:43-49, 1991.
182. Olney JW: Brain lesion, obesity and other disturbances in mice treated with monosodium glutamate. Science 164:719-721, 1969.
183. Olney JW: Neurotoxicity of excitatory amino acids, in McGeer EG, Olney JW, McGeer PL (eds): Kainic Acid As a Tool in Neurobiology. New York, Raven Press, 1978, pp 95-121.
184. Opitz T, Reymann KG: Blockade of metabotropic glutamate receptors protects rat CA1 neurons from hypoxic injury. Neuroreport 2:455-457, 1991.
185. Ozawa K, Seta K, Araki H, Handa H: The effect of ischemia on mitochondrial metabolism. J Biol Chem 61:512-514, 1966.
186. Ozyurt E, Graham DI, Woodruff GN, McCulloch J: Protective effect of the glutamate antagonist MK-801 in focal cerebral ischemia in the cat. J Cereb Blood Flow Metab 8:138-143, 1988.
187. Park CK, Nehls DG, Graham DI, Teasdale GM, McCulloch J: The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann Neurol 24:543-551, 1988.
188. Park CK, Nehls DG, Graham DI, Teasdale GM, McCulloch J: Focal cerebral ischemia in the cat: Treatment with the glutamate antagonist MK-801 after induction of ischemia. J Cereb Blood Flow Metab 8:757-762, 1988.
189. Pellegrini-Giampietro DE, Cherici G, Alesiani M, Carla V, Moroni F: Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J Neurosci 10:1035-1041, 1990.
190. Pellegrini-Giampietro DE, Zukin RS, Bennett MVL, Cho S, Pulsinelli WA: Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc Natl Acad Sci U S A 89:10499-10503, 1992.
191. Petito CK, Feldmann E, Pulsinelli WA, Plum F: Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology 37:1281-1286, 1987.
192. Potter H, Nelson RB, Das S, Siman R, Kayyali US, Dressler D: The involvement of proteases, protease inhibitors, and an acute phase response in Alzheimer's disease. Ann N Y Acad Sci 674:161-173, 1992.
193. Pruss RM, Akeson RL, Racke MM, Wilburn JL: Agonist-activated cobalt uptake identifies divalent cation-permeable kainate receptors on neurons and glial cells. Neuron 7:509-518, 1991.
194. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson MD: Programmed cell death and the control of cell survival: Lessons from the nervous system. Science 262:695-700, 1993.
195. Randall RD, Thayer SA: Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons. J Neurosci 12:1882-1895, 1992.
196. 2+ channels in rat central and peripheral neurons: High-threshold current resistant to dihydropyridine blockers and ω-conotoxin. Neuron 6:269-280, 1991.
197. Rehncrona S, Mela L, Siesjo BK: Recovery of brain mitochondrial function in the rat after complete and incomplete cerebral ischemia. Stroke 10:437-446, 1979.
198. Roberts WM: Spatial calcium buffering in saccular hair cells. Nature 363:74-76, 1993.
199. Roberts WM: Localization of calcium signals by a mobile calcium buffer in frog saccular hair cells. J Neurosci 15:3246-3262, 1994.
200. Roberts-Lewis JM, Siman R: Spectrin proteolysis in the hippocampus: A biochemical marker for neuronal injury and neuroprotection. Ann N Y Acad Sci 679:78-86, 1993.
201. Roberts-Lewis JM, Marcy VR, Zhao Y, Vaught JL, Siman R, Lewis ME: Aurintricarboxylic acid protects hippocampal neurons from NMDA- and ischemia-induced toxicity in vivo. J Neurochem 61:378-381, 1993.
202. Roberts-Lewis JM, Savage MJ, Marcy VR, Pinsker LR, Siman R: Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic brain. J Neurosci 14:3934-3944, 1994.
203. Robitaille R, Charlton MP: Presynaptic calcium signals and transmitter release are modulated by calcium-activated potassium channels. J Neurosci 12:297-305, 1992.
204. Robitaille R, Adler EM, Charlton MP: Strategic location of calcium channels at transmitter release sites of frog neuromuscular synapses. Neuron 5:773-779, 1990.
205. Robitaille R, Garcia ML, Kaczorowski GJ, Charlton MP: Functional colocalization of calcium and calcium-gated potassium channels in control of transmitter release. Neuron 11:645-655, 1993.
206. Rod MR, Auer RN: Combination therapy with nimodipine and dizocilpine in a rat model of transient forebrain ischemia. Stroke 23:725-732, 1992.
207. Rodorf G, Koroshetz WJ, Bonventre JV: Heat shock proteins protect cultured neurons from glutamate toxicity. Neuron 7:1043-1051, 1991.
208. Roine RO, Kaste M, Kinnunen A, Nikki P, Sarna S, Kajaste S: Nimodipine after resuscitation from out-of-hospital ventricular fibrillation: A placebo-controlled, double-blind, randomized trial. JAMA 264:3171-3177, 1990.
209. Ronne-Engstrom E, Hillered L, Flink R, Spannare B, Ungerstedt U, Carlson H: Intracerebral microdialysis of extracellular amino acids in the human epileptic focus. J Cereb Blood Flow Metab 12:873-876, 1992.
210. Rosenberg PA, Aizenman E: Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor culture of rat cerebral cortex. Neurosci Lett 103:162-168, 1989.
211. Rosenberg PA, Amin S, Leitner M: Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture. J Neurosci 12:56-61, 1992.
212. Rothman SM: Synaptic activity mediates death of hypoxic neurons. Science 220:536-537, 1983.
213. Rothman SM: Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J Neurosci 4:1884-1891, 1984.
214. Rothman SM, Olney JW: Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19:105-111, 1986.
215. Rothman SM, Olney JW: Excitotoxicity and the NMDA receptor. Trends Neurosci 10:299-302, 1987.
216. Rothman SM, Thurston JH, Hauart RE: Delayed neurotoxicity of excitatory amino acids in vitro. Neuroscience 22:471-480, 1987.
217. Sako K, Kobatake K, Yamamoto YL, Diksic M: Correlation of local cerebral blood flow, glucose utilization and tissue pH following a middle cerebral artery occlusion in the rat. Stroke 16:828-834, 1985.
218. Sala F, Hernandez-Cruz A: Calcium diffusion modeling in a spherical neuron: Relevance of buffering properties. Biophys J 57:313-324, 1990.
219. Sanada T, Pitts LH, Nishimura M, Byrd S, Isayama K: The effect of nimodipine following experimental head injury in rats, in Scriabine A, Teasdale GM, Tettenborn D, Young W (eds): Nimodipine, Pharmacological and Clinical Results in Cerebral Ischemia. New York, Springer-Verlag, 1990, pp 241-247.
220. Schanne FAX, Kane AB, Young EA, Farber JL: Calcium dependence of toxic cell death: A final common pathway. Science 206:700-702, 1979.
221. Scharfman HE, Schwartzkroin PA: Protection of dentate hilar cells from prolonged stimulation by intracellular calcium chelation. Science 246:257-260, 1989.
222. Schlaepfer WW, Bunge RP: Effects of calcium ion concentration on the degeneration of amputated axons in tissue culture. J Cell Biol 59:456-470, 1973.
223. Schlaepfer WW, Zimmerman UJ: Mechanisms underlying the neuronal response to ischemic injury: Calcium-activated proteolysis of neurofilaments. Prog Brain Res 63:185-196, 1985.
224. Schmidley JW: Free radicals in central nervous system ischemia. Stroke 21:1086-1090, 1990.
225. Schuman EM, Madison DV: A requirement for the intracellular messenger nitric oxide in long term potentiation. Science 254: 1503-1506, 1991.
226. Schutz H, Silverstein PR, Vapalahti M, Bruce DA, Mela L, Langfitt TW: Brain mitochondrial function after ischemia and hypoxia: I - Ischemia induced by increased intracranial pressure. Arch Neurol 29:408-416, 1973.
227. Schutz H, Silverstein PR, Vapalahti M, Bruce DA, Mela L, Langfitt TW: Brain mitochondrial function after ischemia and hypoxia: II - Normotensive systemic hypoxemia. Arch Neurol 29: 417-419, 1973.
228. Schwartzkroin PA, Stafstrom CE: Effects of EGTA on the calcium-activated after-hyperpolarization in hippocampal CA3 pyramidal cells. Science 210:1125-1126, 1980.
229. Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honore T: 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: A neuroprotectant for cerebral ischemia. Science 247:571-574, 1990.
230. Sher PK, Hu SX: Increased glutamate uptake and glutamine synthetase activity in neuronal cell cultures surviving chronic hypoxia. Glia 3:350-357, 1990.
231. Shi RY, Lucas JH, Wolf A, Gross GW: Calcium antagonists fail to protect mammalian spinal neurons after physical injury. J Neurotrauma 6:261-278, 1989.
232. Siesjo BK: Mechanisms of ischemic brain damage. Crit Care Med 16:954-963, 1988.
233. Siesjo BK: Pathophysiology and treatment of focal cerebral ischemia: Part I - Pathophysiology. J Neurosurg 77:169-184, 1992.
234. Siesjo BK: Pathophysiology and treatment of focal cerebral ischemia: Part II - Mechanisms of damage and treatment. J Neurosurg 77:337-354, 1992.
235. Siesjo BK, Bengtsson F: Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: A unifying hypothesis. J Cereb Blood Flow Metab 9:127-140, 1989.
236. Siesjo BK, Katsura K, Tibor K: Acidosis related brain damage, in Siesjo BK, Wieloch T (eds): Advances in Neurology: Cellular and Molecular Mechanisms of Ischemic Brain Damage. New York, Raven Press (in press).
237. 2+] in hypoxia and ischemia in rat brain in vivo. J Gen Physiol 95:837-866, 1990.
238. Silver RA, Lamb AG, Bolsover SR: Calcium hot spots caused by L-channel clustering promote morphological changes on neuronal growth cones. Nature 343:751-754, 1990.
239. Siman R: Proteolytic mechanism for the neurodegeneration of Alzheimer's disease. Ann N Y Acad Sci 674:193-202, 1992.
240. Siman R, Noszek JC: Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron 1:279-287, 1988.
241. Siman R, Noszek C, Kegerise C: Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J Neurosci 9:1579-1590, 1989.
242. Simon RP, Griffiths T, Evans MC, Swan JH, Meldrum BS: Calcium overload in selectively vulnerable neurons of the hippocampus during and after ischemia: An electron microscopy study in the rat. J Cereb Blood Flow Metab 4:350-361, 1984.
243. Simon RP, Swan JH, Meldrum BS: Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 226:850-852, 1984.
244. Skaper SD, Facci L, Milani D, Leon A: Monosialoganglioside GM1 protects against anoxia-induced neuronal death in vitro. Exp Neurol 106:297-305, 1989.
245. Smith SJ, Augustine GJ: Calcium ions, active zones, and synaptic transmitter release. Trends Neurosci 11:458-464, 1988.
246. Southam ES, East SJ, Garthwaite J: Excitatory amino acid receptors coupled to the nitric oxide/cyclic GMP pathway in rat cerebellum during development. J Neurochem 56:2072-2081, 1991.
247. Speksnijder JE, Miller AL, Weisenseel MH, Chen TH, Jaffe LF: Calcium buffer injections block fucoid egg development by facilitating calcium diffusion. Proc Natl Acad Sci U S A 86:6607-6611, 1989.
248. Spitzer NC, Gu X, Oison E: Action potentials, calcium transients and the control of differentiation of excitable cells. Curr Opin Neurobiol 4:70-77, 1994.
249. Steen PA, Newberg LA, Milde JH, Michenfelder JD: Cerebral blood flow and neurologic outcome when nimodipine is given after complete cerebral ischemia in the dog. J Cereb Blood Flow Metab 4:82-87, 1984.
250. Stern MD: Buffering of calcium in the vicinity of a channel pore. Cell Calcium 13:183-192, 1992.
251. Strautman AF, Cork RJ, Robinson KR: The distribution of free calcium in transected spinal axons and its modulation by applied electrical fields. J Neurosci 10:3564-3575, 1990.
252. Stys PK, Ransom BR, Waxman SG: Tertiary and quaternary local anesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability. J Neurophysiol 67:236-240, 1992.
253. Stys PK, Ransom BR, Waxman SG, Davis PK: Role of extracellular calcium in anoxic injury of mammalian central white matter. Proc Natl Acad Sci U S A 87:4212-4216, 1990.
254. 2+ exchanger. J Neurosci 12:430-439, 1992.
255. Taira T, Smirnov S, Voipio J, Kaila K: Intrinsic proton modulation of excitatory transmission in rat hippocampal slices. Neuroreport 4:93-96, 1993.
256. Tator CH: Review of experimental spinal cord injury with emphasis on the local and systemic circulatory effects. Neurochirurgie 37:291-302, 1991.
257. Tator CH: Ischemia as a secondary neural injury, in Salzman SK, Faden AI (eds): Neurobiology of Central Nervous System Trauma. New York, Oxford University Press, 1994, pp 209-215.
258. Tator CH, Fehlings MG: Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 75:15-26, 1991.
259. Teasdale G, Bailey I, Bell A, Gray J, Gullan R, Heiskanan O, Marks PV, Marsh H, Mendelow DA, Murray G, Ohman J, Quaghebeur G, Sinar J, Skene A, Waters A: A randomized trial of nimodipine in severe head injury: HIT I - British/Finnish Co-operative Head Injury Trial Group. J Neurotrauma 9[Suppl 2]:S545-S550, 1992.
260. Tecoma ES, Monyer H, Goldberg MP, Choi DW: Traumatic neuronal injury in vitro is attenuated by NMDA antagonists. Neuron 2:1541-1545, 1989.
261. Thayer SA, Miller RJ: Regulation of the intracellular free calcium concentration in single rat dorsal root ganglion neurones in vitro. J Physiol 425:85-115, 1990.
262. Thompson S, Coombs J: Spatial distribution of Ca currents in molluscan neuron cell bodies and regional differences in the strength of inactivation. J Neurosci 8:1929-1939, 1992.
263. i in permeabilised pancreatic acinar cells. Biochem Biophys Res Comm 192:854-859, 1993.
264. Tombaugh GC, Sapolsky RM: Mechanistic distinctions between excitotoxic and acidotic hippocampal damage in an in vitro model of ischemia. J Cereb Blood Flow Metab 10:527-535, 1990.
265. Tominaga T, Kure S, Yoshimoto T: Temporal profile of DNA degradation in injured rat brain. J Cereb Blood Flow Metab 13[Suppl 1]:S460, 1993 (abstr).
266. Trifaro JM, Vitale ML: Cytoskeleton dynamics during neurotransmitter release. Trends Neurosci 16:466-472, 1993.
267. Tsien RY: New calcium indicators and buffers with high selectivity against magnesium and protons: Design, synthesis, and properties of prototype structures. Biochemistry 19:2396-2404, 1980.
268. Tsien RY: A nondisruptive technique for loading calcium buffers and indicators into cells. Nature 290:527-528, 1981.
269. Tymianski M: Cytosolic calcium concentrations and cell death in vitro, in Siesjo BK, Wieloch T (eds): Advances in Neurology: Cellular and Molecular Mechanisms of Ischemic Brain Damage. New York, Raven Press (in press).
270. Tymianski M, Tator CH: The direct effects of nimodipine on intracellular calcium in spinal neurons in expiant culture. Drugs Dev 2:337-347, 1993.
271. 2+ overload indicates early neuronal injury which precedes staining with viability indicators. Brain Res 607:319-323, 1993.
272. Tymianski M, Charlton MP, Carlen PL, Tator CH: Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J Neurosci 13:2085-2104, 1993.
273. i and glutamate neurotoxicity in vitro. J Neurophysiol 267:1973-1992, 1994.
274. 2+ chelators. J Cereb Blood Flow Metab 14:911-923, 1994.
275. 2+ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo. Neuron 11:221-235, 1993.
276. Tymianski M, Wallace MC, Uno M, Spigelman I, Charlton MP, Carlen PL, Tator CH: Successful treatment of focal ischemic stroke by intracellular calcium chelation. J Cereb Blood Flow Metab 13[Suppl 1]:S638, 1993 (absrr).
277. Tymianski M, Wang LY, MacDonald JF: Enhancement of neuroprotection by chronic depolarization in cultured spinal neurons. Brain Res 648:291-295, 1994.
278. Uematsu D, Araki N, Greenberg JH, Reivich M: Alterations in cytosolic free calcium in the cat cortex during bicuculline-induced epilepsy. Brain Res Bull 24:285-288, 1990.
279. Uematsu D, Greenberg JH, Araki N, Reivich M: Mechanism underlying protective effect of MK-801 against NMDA-induced neuronal injury in vivo. J Cereb Blood Flow Metab 11:779-785, 1991.
280. Uematsu D, Greenberg JH, Hickey WF, Reivich M: Nimodipine attenuates both increase in cytosolic free calcium and histologic damage following focal cerebral ischemia and reperfusion in cats. Stroke 20:1531-1537, 1989.
281. Uematsu D, Greenberg JH, Reivich M, Karp A: In vivo measurement of cytosolic free calcium during cerebral ischemia and reperfusion. Ann Neurol 24:420-428, 1988.
282. Urea G, Urea R: Neurotoxic effects of excitatory amino acids in the mouse spinal cord: Quisqualate and kainate but not N-methyl-D-aspartate induce permanent neural damage. Brain Res 529:7-15, 1990.
283. Vibulsresth S, Dietrich WD, Busto R, Ginsberg MD: Failure of nimodipine to prevent ischemic neuronal damage in rats. Stroke 18:210-216, 1987.
284. Vlessis AA, Widener LL, Bartos D: Effect of peroxide, sodium, and calcium on brain mitochondrial respiration in vitro: Potential role in cerebral ischemia and reperfusion. J Neurochem 54:1412-1418, 1990.
285. Wahlestedt C, Golanov E, Yamamoto S, Yee F, Ericson H, Yoo H, Inturrisi CE, Reis DJ: Antisense oligonucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature 363:260-263, 1993.
286. Walker JB, Harris M: GM-I ganglioside administration combined with physical therapy restores ambulation in humans with chronic spinal cord injury. Neurosci Lett 161:174-178, 1993.
287. Wang Q, Paulson OB, Lassen NA: Effect of nitric oxide blockade by NG-nitro-L-alginin on cerebral blood flow response to changes in carbon dioxide tension. J Cereb Blood Flow Metab 12:947-953, 1992.
288. Waxman SG, Black JA, Ransom BR, Stys PK: Protection of the axonal cytoskeleton in anoxic optic nerve by decreased extracellular calcium. Brain Res 614:137-145, 1993.
289. Weiss J, Goldberg MP, Choi DW: Ketamine protects cultured neocortical neurons from hypoxic injury. Brain Res 380:186-190, 1986.
290. Weiss JH, Hartley DM, Koh J, Choi DW: The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity. Science 247:1474-1477, 1990.
291. Weiss JH, Koh JY, Baimbridge KG, Choi DW: Cortical neurons containing somatostatin- or parvalbumin-like immunoreactivity are atypically vulnerable to excitotoxic injury in vitro. Neurology 40:1288-1292, 1990.
292. Werth JL, Thayer SA: Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons. J Neurosci 14:348-356, 1994.
293. Wolf AL, Levi L, Marmarou A, Ward JD, Muizelaar JP, Choi S, Young H, Rigamonti D, Robinson WL: Effect of THAM upon outcome in severe head injury: A randomized prospective clinical trial. J Neurosurg 78:54-59, 1993.
294. Worley PF, Baraban JM, Synder SH: Beyond receptors: Multiple second-messenger systems in brain. Ann Neurol 21:217-229, 1987.
295. Yamamoto S, Golanov EV, Berger SB, Reis DJ: Inhibition of nitric oxide synthesis increases focal ischemic infarction in rat. J Cereb Blood Flow Metab 12:717-726, 1992.
296. Yang G, Chan PH, Chen J, Carlson E, Chen SF, Weinstein P, Epstein CJ, Kamii H: Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 25:165-170, 1994.
297. Young W, Koreh I: Potassium and calcium changes in injured spinal cords. Brain Res 365:42-53, 1986.
298. 2+ influx in developing neocortex by excitatory and inhibitory neurotransmitters. Neuron 6:333-344, 1991.
299. Zhou Z, Neher E: Mobile and immobile calcium buffers in bovine adrenal chromaffin cells. J Physiol 469:245-273, 1993.
300. Zivin JA, Kochhar A, Saitoh T: Protein phosphorylation during ischemia. Stroke 21[Suppl III]:III-117-III-121, 1990.